<DOC>
	<DOCNO>NCT02219087</DOCNO>
	<brief_summary>The purpose study determine whether liposomal bupivacaine effective management pain follow total knee arthroplasty , compare standard care analgesia .</brief_summary>
	<brief_title>Liposomal Bupivacaine Versus Standard Care Total Knee Surgery</brief_title>
	<detailed_description>Liposomal bupivacaine ( Exparel® ) local anesthetic make liposomal encapsulated bupivacaine . It design injected time surgery local soft tissue . Because unique liposomal delivery system , Liposomal bupivacaine ( Exparel® ) show provide 96 hour pain relief follow surgery . This make attractive option total knee arthroplasty patient . Combined proven efficacy regional anesthesia , intraoperative liposomal bupivacaine ( Exparel® ) may provide extend pain relief follow total knee arthroplasty . This potential avoid need opioid medication . With good pain control , medication side effect avoid patient 's length stay hospital shorten .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>At least 18 year age Scheduled undergo total knee arthroplasty ( TKA ) perform principal investigator Age &lt; 18 year Pregnant breastfeed NonEnglishspeaking Unable give inform consent Patients admit discharged medical facility ( due likelihood limited mobility and/or require minimum lengths stay , confound primary outcome ) , include hospital , skilled nursing facility , longterm acute care hospital , etc . Patients unable complete deviceassisted 140 foot walk baseline Patients contraindication ( ) bupivacaine ropivacaine formulation , nerve block local agent use ( IV morphine , ketorolac , methylprednisolone ) . Patients longacting maintenance opioid prior admission surgery ( e.g. , methadone , oxycontin ) Patients undergo simultaneous bilateral TKAs , would increase dose Exparel per patient ( limited one dose per patient )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Total joint arthroplasty</keyword>
	<keyword>Knee replacement</keyword>
	<keyword>Osteoarthritis knee</keyword>
</DOC>